| | | | | | | | | |

Mesothelioma Research Gets a Boost From New Tissue Bank

ByAlex Strauss

495116_tissue smallA new biobank of mesothelioma cell samples in the UK is set to help advance mesothelioma research around the world.

The recently-opened mesothelioma tissue bank, called MesobanK UK, will be an international resource of cells specifically for use in mesothelioma research.

Mesothelioma Cell Samples and More

When the biobank is complete within the next few years, it is expected to contain samples of tissue, blood and pleural fluid from 300 patients with mesothelioma as well as 26 new mesothelioma cell lines.

In addition to these cells, which are vital for mesothelioma research, the biobank will also include details from the medical records of these mesothelioma patients, collected by permission.

“MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised [made anonymous] clinical data,” says Dr. Robert Rintoul of Papworth Hospital in Cambridge where the mesothelioma tissue bank is housed.

The Importance of a Mesothelioma Biobank

Biobanks or tissue banks are storage facilities for biological samples that mesothelioma researchers need to develop and test news drugs and theories about underlying causes and potential cures.

Because mesothelioma is such a rare cancer, it is important for researchers to have access to a collection of blood, pleural fluid, and tissue samples for testing.

A Standardized Tissue Bank for Mesothelioma Research

Although several countries maintain mesothelioma tissue banks, the samples themselves are often housed at different institutions and there may be no standard practice for their collection.

“Although a few UK-based clinical/research groups hold fresh tissue from small numbers of patients with malignant pleural mesothelioma, these collections are not formally linked and do not involve the collection of tissue and data in accordance with any universal standard operating procedures,” says Dr. Rintoul.

In contrast, MesobanK UK’s tissue, blood, and lung fluid samples will be collected according to a strict set of standards and will be housed in one location. Samples will be usable for up to ten years.

How Mesothelioma Tissue Samples Will Be Used

MesobanK UK plans to collect about 100 sample sets a year from mesothelioma patients. Samples will be supplied to researchers who request them, as long as they meet the following conditions:

  1. They are conducting research linked to improving prevention, diagnosis and treatment of mesothelioma or asbestos-related disease
  2. They agree to acknowledge MesobanK in publications
  3. They agree to share the data they glean from research conducted on MesobanK samples

The tissue bank is also creating a microarray test that researchers can use to evaluate potential new mesothelioma biomarkers. It is being developed using mesothelioma tissue samples from 750 mesothelioma patients.

The UK has the highest per capita rate of asbestos-related disease in the world.

Source:

Rintoul, R, et al, “MesobanK UK: An international mesothelioma bioresource”, Thorax, October 14, 2015, Epub ahead of print

Similar Posts

Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers
| |

Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

ByAlex Strauss

Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma
| |

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

ByAlex Strauss

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

Mesothelioma Still Rising Despite Ban in Ireland
|

Mesothelioma Still Rising Despite Ban in Ireland

ByAlex Strauss

A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

Does Radiotherapy Reduce Mesothelioma Pain?
| |

Does Radiotherapy Reduce Mesothelioma Pain?

ByAlex Strauss

A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

Website Aims to Protect Homeowners from Mesothelioma
|

Website Aims to Protect Homeowners from Mesothelioma

ByAlex Strauss

Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

Ape Virus Shrinks Mesothelioma Tumors in Lab
|

Ape Virus Shrinks Mesothelioma Tumors in Lab

ByAlex Strauss

A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…